Home

Results 51 - 60 of 158,708 for medicinal advantages. Search took 4.656 seconds.  
Sort by date/Sort by relevance
There is already progress to cheer from the dramatic increase in wind and solar energy and global energy transition Papua New Guinea is yet to take advantage of. With serious investment in renewable and decentralized energy, Papua New Guinea could usher in its independence on imported refined fossil fuels. (...) Papua New Guinea needs to start closing the digital divide and enable its citizens to participate in the digital economy, take advantage of artificial intelligence, distance learning, tele-medicine, and other digital transformations. (...) Papua New Guinea needs to start closing the digital divide and enable its citizens to participate in the digital economy, take advantage of artificial intelligence, distance learning, tele-medicine, and other digital transformations.
Language:English
Score: 1122365.8 - https://www.undp.org/papua-new...-ignoring-world-breaking-point
Data Source: un
Furthermore, intellectual property rules have increased the cost of access to some medicines and can jeopardize full enjoyment of the right to health. Through two case studies it is shown that diverse practices, permitted under current trade regulations, have extended the duration of intellectual property protection and made medicines more expensive. The report concludes that challenges exist for harmonizing international law on these matters and taking advantage of the flexibilities provided for in the agreements. (...) Although the right to public health has been strengthened in recent decades – as evidenced by the development of numerous international legal instruments as well as instruments to facilitate access to medicines and technologies – it is necessary to deepen and clarify it and move towards mechanisms that facilitate access to medicines as an indispensable aspect of the right to health, the Commission adds.
Language:English
Score: 1122018.2 - https://www.cepal.org/en/news/...-property-and-access-medicines
Data Source: un
Article 7 of the TRIPS Agreement recognises this balance, providing that "the protection and enforcement of intellectual property rights should contribute to the promotion of technological innovation and to the transfer and dissemination of technology, to the mutual advantage of producers and users of technological knowledge and in a manner conducive to social and economic welfare, and to a balance of rights and obligations". (...) Specific issues address by the TRIPS Council under this ad hoc agenda item include: Compulsory licensing Follow-up discussion on compulsory licensing Regulatory review exception Promoting public health through competition law and policy R&D costs and pricing of medicines and health technologies Intellectual property and the public interest: The WTO TRIPS Agreement and the copyright three-step test Intellectual property and the public interest: Beyond access to medicines and medical technologies toward a more holistic approach to TRIPS flexibilities e-TRIPS Gateway: TRIPS Council Minutes e-TRIPS Gateway: TRIPS Council Minutes Communications to the TRIPS Council Share    Problems viewing this page?
Language:English
Score: 1121330.8 - https://www.wto.org/english/tr...rips_and_public_interest_e.htm
Data Source: un
“Panama aims to capitalize on its existing geographic and market access advantages related to the expanded Panama Canal,” said Guardia de Rubinoff. (...) “Together, we can also explore opportunities to integrate backward into the manufacture of finished pharmaceutical products as well as possibly into research and development of new, innovative medicines.” For more than 13 years, UNIDO has been involved in fostering local pharmaceutical production in developing and least developed countries through advisory and capacity building interventions that seek to strengthen the operating environment for pharmaceutical manufacturers, with the ultimate objective to improve access to quality medicines and hence make a positive contribution to public health and industrial development objectives at the same time.
Language:English
Score: 1121330.8 - https://www.unido.org/news/uni...egy-develop-pharmaceutical-hub
Data Source: un
As regards the following: Access to essential medicines The delegation of the Central African Republic welcomes the decision to authorize access to essential medicines for countries that lack manufacturing facilities. (...) Special and differential treatment The delegation of the Central African Republic also has concerns regarding the review of the provisions on special and differential treatment with a view to strengthening them and making them more advantageous for the least-developed countries, which are facing great difficulties in formulating trade policies, effectively participating in negotiations, and implementing the multilateral trade agreements. At Cancún, but above all, after Cancún 2003, I ask you not to turn away from such essential issues as the sectoral initiative on cotton, effective access to essential medicines for populations in poor countries, and the in-depth reform of special and differential treatment to which I have just referred.
Language:English
Score: 1118515.2 - https://www.wto.org/english/th...min03_e/statements_e/st132.doc
Data Source: un
As regards the following: Access to essential medicines The delegation of the Central African Republic welcomes the decision to authorize access to essential medicines for countries that lack manufacturing facilities. (...) Special and differential treatment The delegation of the Central African Republic also has concerns regarding the review of the provisions on special and differential treatment with a view to strengthening them and making them more advantageous for the least-developed countries, which are facing great difficulties in formulating trade policies, effectively participating in negotiations, and implementing the multilateral trade agreements. At Cancún, but above all, after Cancún 2003, I ask you not to turn away from such essential issues as the sectoral initiative on cotton, effective access to essential medicines for populations in poor countries, and the in-depth reform of special and differential treatment to which I have just referred.
Language:English
Score: 1118515.2 - https://www.wto.org/english/th...min03_e/statements_e/st132.pdf
Data Source: un
Paragraph 6 of the Doha Declaration addresses one particular concern with the TRIPS agreement, namely the case where a country that has a patent on a medicine cannot find an efficient, affordable and reliable source of medicines, due to TRIPS restrictions on production and export of medicines. (...) The Article 30 approach to addressing the issue of exports of medicines (and other health care inventions) is not the only possible solution to this problem, but it has many advantages, including for example: 1. (...) Under Article 30 of the TRIPS Agreement, Members may, among others, authorize the production and export of medicines by persons other than holders of patents on those medicines to address public health needs in importing Members”.
Language:English
Score: 1118340 - https://www.wto.org/english/forums_e/ngo_e/joint_trips.doc
Data Source: un
Therefore, WHO has established the AIDS Medicines and Diagnostics Service (AMDS) to assist countries with all aspects of selecting, procuring and delivering AIDS medicines and diagnostic tools to the point of service delivery. (...) FDCs are a major breakthrough for AIDS treatment in poor countries as they offer significant operational advantages, including ease of distribution and storage, the likelihood of greater adherence, reduced incidence of treatment failure and drug resistance. (...) Prequalification was originally intended to give United Nations procurement agencies such as UNICEF the choice of a range of quality medicines. With time, the growing list of medicines that have been found to meet the set requirements has come to be seen as a useful tool for anyone purchasing medicines in bulk, including national governments and other organizations.
Language:English
Score: 1117111.1 - https://www.who.int/3by5/changinghistory/en/
Data Source: un
It is collaborating with partners to strengthen the evidence base and develop new responses to this global threat. o WHO is working closely with FAO and OIE in a ‘One Health’ approach to promote best practices to avoid the emergence and spread of antibacterial resistance, including optimal use of antibiotics in both humans and animals. o http://www.who.int/antimicrobial-resistance/national-action-plans/library/en/ http://www.who.int/antimicrobial-resistance/national-action-plans/library/en/ Status based on WHO Website Country WHO Website Bangladesh 2017-2022; DG Fisheries China 2016-2020; Ministry of Agriculture Croatia Hongkong SAR India 2017-2021; ICAR Indonesia 2017-2019; Tripartite; Ministry of Fisheries Malaysia Country National Action Plan China 1.To exploit advantages of joint prevention and control, and fulfill the department responsibility 2.To increase investment in research and development of antimicrobials 3.To strengthen the management of antibacterial agents supply security. 4.To strengthen the construction of antibacterial agent application and antimicrobial resistance control system. 5.To optimize antimicrobials consumption and antimicrobial resistance surveillance system 6.To improve the capacity of professional personnel in antimicrobial resistance prevention and control 7.To strengthen the prevention and management of environmental pollution of antimicrobials 8.To strengthen publicity and education of antimicrobial resistance 9.To conduct extensive international exchanges and cooperation Indonesia 1. (...) Optimise use of antimicrobial medicines 5. Build investments in new medicines, diagnostic tools and vaccines Status based on WHO Website Country WHO Website Netherlands 2015-2019; Ministry of Health to Dutch House of Representatives Philippines 2015-2020: DoH, DOST, DA, BFAR; One Health Singapore Spain 2014-2018 Sri Lanka 2017-2022; MoFAR Thailand 2016-2021, One Health; Ministry of Agriculture and Cooperatives (MOAC), Tripartite, ASEAN, SAARC Viet Nam 2013-2020; Departments of Ministry of Agriculture and Rural Development; Livestock, poultry, aquaculture and cultivation Country National Action Plan Philippines 1. (...) Ensure uninterrupted access to essential medicines of assured quality 4. Regulate and promote rational use of medicines, including in animal husbandry and ensure proper patient care 5.
Language:English
Score: 1116706.25 - https://www.fao.org/fishery/st...20Dec%202017/10%20Reantaso.pdf
Data Source: un
With his indigenous knowledge coupled with scientific knowledge, he is now providing solutions to health challenges with certified herbal medicines in Ghana. Enoch was certified as a Medical Herbalist at age 26 after successfully completing professional qualifying examinations in plant medicine and a Bachelor of Science degree in Herbal Medicine from the University. (...) According to the World Health Organization (WHO), traditional medicine backed with scientific methods, tools and guidelines can make a significant contribution to provide better access to medicines and achieving universal health coverage in Africa. (...) The vision of the two young entrepreneurs is to scale up production, so they can take advantage of the African Continental Free Trade Area (AfCFTA) agreement, to supply to other African countries.
Language:English
Score: 1116585.6 - https://www.undp.org/ghana/news/healing-plants
Data Source: un